This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.
Immunocore has raised a $130 million (€117 million) series B round, ending its long...
Fortress Biotech has licensed a treatment for KRAS-driven cancers from Columbia...
Paired with chemotherapy, Venclexta succeeded in a Phase 3 acute myeloid leukemia...
Credit: (C) 2020, American Geriatrics Society Representing more than 6,000 healthcare...
Credit: Mary Ann Liebert, Inc., publishers New Rochelle, NY, April 20, 2020–A group...
It’s been just over two years since INC Research and inVentiv came together in a...